Xianlong Gao1, Xiaomin Wu1, Jiajie Yan1,2, Jingqun Zhang3, Weiwei Zhao1,2, Dominic DeMarco1,2, Yongguo Zhang4, Mamdouh Bakhos5, Gregory Mignery1, Jun Sun4, Zhenyu Li6, Michael Fill2, Xun Ai1,2. 1. Department of Cell and Molecular Physiology, Loyola University Chicago, Maywood, IL, USA. 2. Department of Physiology and Biophysics, Rush University Medical Center, Chicago, IL, USA. 3. Department of Cardiology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, PR China. 4. Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA. 5. Department of Thoracic & Cardiovascular Surgery, Loyola University Chicago, Maywood, IL, USA. 6. Division of Cardiovascular Medicine, University of Kentucky, KY, USA.
Abstract
Aims: c-jun N-terminal kinase (JNK) is a critical stress response kinase that activates in a wide range of physiological and pathological cellular processes. We recently discovered a pivotal role of JNK in the development of atrial arrhythmias in the aged heart, while cardiac CaMKIIδ, another pro-arrhythmic molecule, was also known to enhance atrial arrhythmogenicity. Here, we aimed to reveal a regulatory role of the stress kinase JNK2 isoform on CaMKIIδ expression. Methods and results: Activated JNK2 leads to increased CaMKIIδ protein expression in aged human and mouse atria, evidenced from the reversal of CaMKIIδ up-regulation in JNK2 inhibitor treated wild-type aged mice. This JNK2 action in CaMKIIδ expression was further confirmed in HL-1 myocytes co-infected with AdMKK7D-JNK2, but not when co-infected with AdMKK7D-JNK1. JNK2-specific inhibition (either by a JNK2 inhibitor or overexpression of inactivated dominant-negative JNK2 (JNK2dn) completely attenuated JNK activator anisomycin-induced CaMKIIδ up-regulation in HL-1 myocytes, whereas overexpression of JNK1dn did not. Moreover, up-regulated CaMKIIδ mRNA along with substantially increased phosphorylation of JNK downstream transcription factor c-jun [but not activating transcription factor2 (ATF2)] were exhibited in both aged atria (humans and mice) and transiently JNK activated HL-1 myocytes. Cross-linked chromatin-immunoprecipitation assays (XChIP) revealed that both c-jun and ATF2 were bound to the CaMKIIδ promoter, but significantly increased binding of c-jun only occurred in the presence of anisomycin and JNK inhibition alleviated this anisomycin-elevated c-jun binding. Mutated CaMKII consensus c-jun binding sites impaired its promoter activity. Enhanced transcriptional activity of CaMKIIδ by anisomycin was also completely reversed to the baseline by either JNK2 siRNA or c-jun siRNA knockdown. Conclusion: JNK2 activation up-regulates CaMKIIδ expression in the aged atrium. This JNK2 regulation in CaMKIIδ expression occurs at the transcription level through the JNK downstream transcription factor c-jun. The discovery of this novel molecular mechanism of JNK2-regulated CaMKII expression sheds new light on possible anti-arrhythmia drug development.
Aims: c-jun N-terminal kinase (JNK) is a critical stress response kinase that activates in a wide range of physiological and pathological cellular processes. We recently discovered a pivotal role of JNK in the development of atrial arrhythmias in the aged heart, while cardiac CaMKIIδ, another pro-arrhythmic molecule, was also known to enhance atrial arrhythmogenicity. Here, we aimed to reveal a regulatory role of the stress kinase JNK2 isoform on CaMKIIδ expression. Methods and results: Activated JNK2 leads to increased CaMKIIδ protein expression in aged human and mouse atria, evidenced from the reversal of CaMKIIδ up-regulation in JNK2 inhibitor treated wild-type aged mice. This JNK2 action in CaMKIIδ expression was further confirmed in HL-1 myocytes co-infected with AdMKK7D-JNK2, but not when co-infected with AdMKK7D-JNK1. JNK2-specific inhibition (either by a JNK2 inhibitor or overexpression of inactivated dominant-negative JNK2 (JNK2dn) completely attenuated JNK activator anisomycin-induced CaMKIIδ up-regulation in HL-1 myocytes, whereas overexpression of JNK1dn did not. Moreover, up-regulated CaMKIIδ mRNA along with substantially increased phosphorylation of JNK downstream transcription factor c-jun [but not activating transcription factor2 (ATF2)] were exhibited in both aged atria (humans and mice) and transiently JNK activated HL-1 myocytes. Cross-linked chromatin-immunoprecipitation assays (XChIP) revealed that both c-jun and ATF2 were bound to the CaMKIIδ promoter, but significantly increased binding of c-jun only occurred in the presence of anisomycin and JNK inhibition alleviated this anisomycin-elevated c-jun binding. Mutated CaMKII consensus c-jun binding sites impaired its promoter activity. Enhanced transcriptional activity of CaMKIIδ by anisomycin was also completely reversed to the baseline by either JNK2 siRNA or c-jun siRNA knockdown. Conclusion:JNK2 activation up-regulates CaMKIIδ expression in the aged atrium. This JNK2 regulation in CaMKIIδ expression occurs at the transcription level through the JNK downstream transcription factor c-jun. The discovery of this novel molecular mechanism of JNK2-regulated CaMKII expression sheds new light on possible anti-arrhythmia drug development.
Authors: Richard M Angell; Francis L Atkinson; Murray J Brown; Tsu Tshen Chuang; John A Christopher; Maria Cichy-Knight; Allison K Dunn; Kendra E Hightower; Susanna Malkakorpi; James R Musgrave; Margarete Neu; Paul Rowland; Robyn L Shea; Jeffery L Smith; Donald O Somers; Sonia A Thomas; Gladstone Thompson; Ruolan Wang Journal: Bioorg Med Chem Lett Date: 2006-12-15 Impact factor: 2.823
Authors: Magdalena Juhaszova; Christophe Rabuel; Dmitry B Zorov; Edward G Lakatta; Steven J Sollott Journal: Cardiovasc Res Date: 2005-05-01 Impact factor: 10.787
Authors: Tong Zhang; Tao Guo; Shikha Mishra; Nancy D Dalton; Evangelia G Kranias; Kirk L Peterson; Donald M Bers; Joan Heller Brown Journal: Circ Res Date: 2009-12-03 Impact factor: 17.367
Authors: Stefan Neef; Nataliya Dybkova; Samuel Sossalla; Katharina R Ort; Nina Fluschnik; Kay Neumann; Ralf Seipelt; Friedrich A Schöndube; Gerd Hasenfuss; Lars S Maier Journal: Circ Res Date: 2010-01-07 Impact factor: 17.367
Authors: Michael Wester; Anton Heller; Michael Gruber; Lars S Maier; Christian Schach; Stefan Wagner Journal: PLoS One Date: 2019-09-09 Impact factor: 3.240